80 related articles for article (PubMed ID: 25111481)
1. Specific inhibition of DNMT1/CFP1 reduces cancer phenotypes and enhances chemotherapy effectiveness.
Cheray M; Nadaradjane A; Bonnet P; Routier S; Vallette FM; Cartron PF
Epigenomics; 2014 Jun; 6(3):267-75. PubMed ID: 25111481
[TBL] [Abstract][Full Text] [Related]
2. Specific Inhibition of DNMT3A/ISGF3γ Interaction Increases the Temozolomide Efficiency to Reduce Tumor Growth.
Cheray M; Pacaud R; Nadaradjane A; Oliver L; Vallette FM; Cartron PF
Theranostics; 2016; 6(11):1988-1999. PubMed ID: 27698935
[TBL] [Abstract][Full Text] [Related]
3. Identifying novel selective non-nucleoside DNA methyltransferase 1 inhibitors through docking-based virtual screening.
Chen S; Wang Y; Zhou W; Li S; Peng J; Shi Z; Hu J; Liu YC; Ding H; Lin Y; Li L; Cheng S; Liu J; Lu T; Jiang H; Liu B; Zheng M; Luo C
J Med Chem; 2014 Nov; 57(21):9028-41. PubMed ID: 25333769
[TBL] [Abstract][Full Text] [Related]
4. Developing new chemical tools for DNA methyltransferase 1 (DNMT 1): a small-molecule activity-based probe and novel tetrazole-containing inhibitors.
Zhu B; Ge J; Yao SQ
Bioorg Med Chem; 2015 Jun; 23(12):2917-27. PubMed ID: 25801160
[TBL] [Abstract][Full Text] [Related]
5. Rapid synthesis of new DNMT inhibitors derivatives of procainamide.
Halby L; Champion C; Sénamaud-Beaufort C; Ajjan S; Drujon T; Rajavelu A; Ceccaldi A; Jurkowska R; Lequin O; Nelson WG; Guy A; Jeltsch A; Guianvarc'h D; Ferroud C; Arimondo PB
Chembiochem; 2012 Jan; 13(1):157-65. PubMed ID: 22170584
[TBL] [Abstract][Full Text] [Related]
6. Silencing DNA methyltransferase (DNMT) enhances glioma chemosensitivity.
Shervington A; Patel R
Oligonucleotides; 2008 Dec; 18(4):365-74. PubMed ID: 18928331
[TBL] [Abstract][Full Text] [Related]
7. DNMT1 and EZH2 mediated methylation silences the microRNA-200b/a/429 gene and promotes tumor progression.
Ning X; Shi Z; Liu X; Zhang A; Han L; Jiang K; Kang C; Zhang Q
Cancer Lett; 2015 Apr; 359(2):198-205. PubMed ID: 25595591
[TBL] [Abstract][Full Text] [Related]
8. Transfection of HCVc improves hTERT expression through STAT3 pathway by epigenetic regulation in Huh7 cells.
Guo N; Cheng D; Li ZH; Zhou QB; Zhou JJ; Lin Q; Zeng B; Liao Q; Chen RF
J Cell Biochem; 2012 Nov; 113(11):3419-26. PubMed ID: 22688977
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitor apicidin downregulates DNA methyltransferase 1 expression and induces repressive histone modifications via recruitment of corepressor complex to promoter region in human cervix cancer cells.
You JS; Kang JK; Lee EK; Lee JC; Lee SH; Jeon YJ; Koh DH; Ahn SH; Seo DW; Lee HY; Cho EJ; Han JW
Oncogene; 2008 Feb; 27(10):1376-86. PubMed ID: 17828306
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids.
Lee WJ; Shim JY; Zhu BT
Mol Pharmacol; 2005 Oct; 68(4):1018-30. PubMed ID: 16037419
[TBL] [Abstract][Full Text] [Related]
11. Glycogen synthase kinase 3β inhibition sensitizes human glioblastoma cells to temozolomide by affecting O6-methylguanine DNA methyltransferase promoter methylation via c-Myc signaling.
Pyko IV; Nakada M; Sabit H; Teng L; Furuyama N; Hayashi Y; Kawakami K; Minamoto T; Fedulau AS; Hamada J
Carcinogenesis; 2013 Oct; 34(10):2206-17. PubMed ID: 23715499
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of DNA methyltransferase activity prevents tumorigenesis in a mouse model of prostate cancer.
McCabe MT; Low JA; Daignault S; Imperiale MJ; Wojno KJ; Day ML
Cancer Res; 2006 Jan; 66(1):385-92. PubMed ID: 16397253
[TBL] [Abstract][Full Text] [Related]
13. DNA methyltransferases in hematologic malignancies.
Li KK; Luo LF; Shen Y; Xu J; Chen Z; Chen SJ
Semin Hematol; 2013 Jan; 50(1):48-60. PubMed ID: 23507483
[TBL] [Abstract][Full Text] [Related]
14. TGF-β induces global changes in DNA methylation during the epithelial-to-mesenchymal transition in ovarian cancer cells.
Cardenas H; Vieth E; Lee J; Segar M; Liu Y; Nephew KP; Matei D
Epigenetics; 2014 Nov; 9(11):1461-72. PubMed ID: 25470663
[TBL] [Abstract][Full Text] [Related]
15. Effects of specific DNMT gene depletion on cancer cell transformation and breast cancer cell invasion; toward selective DNMT inhibitors.
Chik F; Szyf M
Carcinogenesis; 2011 Feb; 32(2):224-32. PubMed ID: 20980350
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of DNA methylation and histone deacetylation prevents murine lung cancer.
Belinsky SA; Klinge DM; Stidley CA; Issa JP; Herman JG; March TH; Baylin SB
Cancer Res; 2003 Nov; 63(21):7089-93. PubMed ID: 14612500
[TBL] [Abstract][Full Text] [Related]
17. Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells.
Yang X; Phillips DL; Ferguson AT; Nelson WG; Herman JG; Davidson NE
Cancer Res; 2001 Oct; 61(19):7025-9. PubMed ID: 11585728
[TBL] [Abstract][Full Text] [Related]
18. Epigenetics and cancer treatment.
Kristensen LS; Nielsen HM; Hansen LL
Eur J Pharmacol; 2009 Dec; 625(1-3):131-42. PubMed ID: 19836388
[TBL] [Abstract][Full Text] [Related]
19. Advances in the computational development of DNA methyltransferase inhibitors.
Medina-Franco JL; Caulfield T
Drug Discov Today; 2011 May; 16(9-10):418-25. PubMed ID: 21315180
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic inactivation of the metastasis suppressor RECK enhances invasion of human colon cancer cells.
Cho CY; Wang JH; Chang HC; Chang CK; Hung WC
J Cell Physiol; 2007 Oct; 213(1):65-9. PubMed ID: 17443689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
